Insuman Comb 50

Insulin Human, the active ingredient in Insuman Comb 50, is an insulin presented as a 50 units/mL solution for subcutaneous use. It lowers blood glucose in people with type 1 and type 2 diabetes mellitus.

GNH USA supplies Insuman Comb 50 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 50 is a premixed insulin that provides both basal and prandial glucose control for diabetes management.

- Type 1 diabetes mellitus: provides basal and rapid‑acting insulin to maintain target glycaemic levels. - Type 2 diabetes mellitus: supplements oral agents when additional glucose lowering is required. - Hyperglycaemic emergencies: delivers a rapid reduction of plasma glucose during acute episodes.

Insuman Comb 50 may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, or confusion. - Weight gain: modest increase in body weight with chronic use. - Injection‑site reactions: redness, swelling, or itching at the injection site. - Lipodystrophy: localized changes in fat tissue under the skin. - Localised allergic reactions: mild rash or urticaria.

Serious or Rare Side Effects: - Severe hypoglycaemia: loss of consciousness or seizures requiring emergency assistance. - Anaphylaxis: life‑threatening systemic allergic response. - Insulin edema: swelling of extremities due to fluid retention. - Hypokalemia: low potassium levels that may affect cardiac rhythm. - Hypocalcemia: reduced calcium levels, potentially causing neuromuscular symptoms.

When using Insuman Comb 50, several safety considerations should be observed.

- Blood‑glucose monitoring: check levels regularly to adjust dose and avoid hypoglycaemia. - Illness or stress: may require temporary dose increase; consult a healthcare professional. - Renal or hepatic impairment: use caution and consider dose modification. - Pregnancy and lactation: safety data are limited; discuss risks with a physician. - Hypoglycaemia history: avoid use if patient has recurrent severe episodes. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Comb 50 can interact with several medicines, altering its glucose‑lowering effect.

Major Interactions (Avoid): - Sulfonylureas or meglitinides: additive risk of severe hypoglycaemia. - Beta‑adrenergic blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can potentiate insulin’s glucose‑lowering action.

Moderate Interactions (Monitor Closely): - Corticosteroids: increase blood glucose, may require higher insulin dose. - Thiazide diuretics: can raise glucose levels modestly. - Oral contraceptives: may affect insulin sensitivity. - Alcohol: can cause unpredictable glucose fluctuations. - Lipid‑lowering agents (e.g., fibrates): occasional reports of altered insulin requirements.